Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 18

Results For "Bridge"

256 News Found

AstraZeneca India expands ‘Ganga Godavari Cancer Screening’ initiative
News | February 04, 2023

AstraZeneca India expands ‘Ganga Godavari Cancer Screening’ initiative

The initiative launched in 2019 has touched over 10,000 lives with 500+ screening camps and aims to double its reach in the next 2 years


Fadnavis inaugurates 310-bed Medicover Hospitals in Navi Mumbai
Healthcare | January 25, 2023

Fadnavis inaugurates 310-bed Medicover Hospitals in Navi Mumbai

Medical Tourism will boost India’s economy


G 20: Medical Value Travel could be focused on maintaining, improving or restoring health through medical intervention: Dr V K Paul
Policy | January 21, 2023

G 20: Medical Value Travel could be focused on maintaining, improving or restoring health through medical intervention: Dr V K Paul

There is a great opportunity for utilizing traditional medical practices like Ayurveda in Value Based Healthcare


Cipla launches Cippoint
News | January 18, 2023

Cipla launches Cippoint

Point-of-Care solution to facilitate clinicians in quick and effective decision making


Dozee partners British International Investment to transform public healthcare in India
Healthcare | January 13, 2023

Dozee partners British International Investment to transform public healthcare in India

The goal of Dozee’s partnership with BII is to improve access to healthcare across India and alleviate the workload of healthcare workers, reduce nurse burnout and fatigue in hospital wards


Quantori partners with Databricks to accelerate data-driven innovation in life sciences
Digitisation | January 02, 2023

Quantori partners with Databricks to accelerate data-driven innovation in life sciences

Quantori develops solutions on the Databricks Lakehouse Platform providing real-time insights


Takeda launches CINRYZE in India for hereditary angioedema patients
News | December 15, 2022

Takeda launches CINRYZE in India for hereditary angioedema patients

CINRYZE is plasma-derived C1-I NH approved for routine prevention (prophylaxis), short-term prevention or pre-procedure prevention, and acute attacks of HAE.


Fraunhofer IZI Selects Lonza’s MODA-ES Solution to Digitalize Manufacturing Operations
News | December 07, 2022

Fraunhofer IZI Selects Lonza’s MODA-ES Solution to Digitalize Manufacturing Operations

GMP-compliant documentation of all manufacturing steps for cell and gene therapies


Telemedicine service eSanjeevani achieves 8 crore teleconsultations
News | December 07, 2022

Telemedicine service eSanjeevani achieves 8 crore teleconsultations

The initiative has garnered the distinction of being the world’s largest government owned telemedicine platform


Lonza’s API manufacturing facility expansion in Nansha starts commercial operation
News | December 06, 2022

Lonza’s API manufacturing facility expansion in Nansha starts commercial operation

Expanded capacity in Nansha, China will support mid-scale manufacturing to ensure a smooth transition between early-phase and large-scale commercial production